Malignancy during methotrexate and steroid therapy for psoriasis.
D000328:Adult; D002294:Carcinoma, Squamous Cell / Q000000981:diagnostic imaging / Q000209:etiology* / Q000473:pathology; D006801:Humans; D007165:Immunosuppression Therapy; D008175:Lung Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects*; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000276:immunology; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects*; D011565:Psoriasis / Q000150:complications / Q000188:drug therapy*; D011859:Radiography; D012878:Skin Neoplasms / Q000209:etiology* / Q000473:pathology
D011241:Prednisone; D008727:Methotrexate